Circulating anti‐Müllerian hormone and breast cancer risk: A study in ten prospective cohorts
Wenzhen Ge(New York University), Anne Zeleniuch‐Jacquotte(New York University), Mengling Liu(Yichang Central People's Hospital), A. Heather Eliassen(Brigham and Women's Hospital), Judith Hoffman–Bolton(Unknown), Karen L. Koenig(New York University), Patrick M. Sluss(Harvard University), Claudia Agnoli(Fondazione IRCCS Istituto Nazionale dei Tumori), Anthony J. Swerdlow(Institute of Cancer Research), Tess V. Clendenen(New York University), Malin Sund(Brigham and Women's Hospital), Hazel B. Nichols(University of North Carolina at Chapel Hill), Roni T. Falk(National Cancer Institute), Dale P. Sandler(University of North Carolina at Chapel Hill), Timothy J. Key(University of Oxford), Joanne F. Dorgan, Louise A. Brinton(National Cancer Institute), Vittorio Krogh(Istituti di Ricovero e Cura a Carattere Scientifico), Yelena Afanasyeva(New York University), Kala Visvanathan(Johns Hopkins University), Minouk J. Schoemaker(Institute of Cancer Research), Göran Hallmans(Aalborg University Hospital), Susan E. Hankinson(University of Massachusetts Amherst)
Cited by 43
Related Papers
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
|The Lancet Public Health|2020|2.3k
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
|The Lancet|1998|1.8k